CARGO Therapeutics (NASDAQ:CRGX) Stock Rating Reaffirmed by

Truist Financial reaffirmed their buy rating on shares of CARGO Therapeutics (NASDAQ:CRGX – Free Report) in a research note released on Thursday morning, Benzinga reports. The firm currently has a $32.00 target price on the stock, down from their prior target price of $34.00. Separately, Jefferies Financial Group boosted their price objective on CARGO Therapeutics […]

Related Keywords

California , United States , American , , Therapeutics Company Profile , American International Group Inc , Nasdaq , Jefferies Financial Group , Therapeutics Inc , Ameritas Investment Partners Inc , Truist Financial , Free Report , Get Free Report , Investment Partners , International Group , Financial Markets , State Teachers Retirement System , Stempoint Capital , Point Capital ,